Asbestos and Mesothelioma

Disseminates for the first time information from a study demonstrating that inherited mutations can influence a person's risk of mesothelioma Addresses the fact that, besides mesothelioma, some of the BAP1 mutation carriers developed ocular melanoma or other cancers, and this cancer susceptibility is now recognized as the BAP1 Syndrome Highlights will be the various molecular signaling pathways that are hyper-activated in this disease, facilitating the identification of novel druggable targets for cancer therapy or prevention Includes supplementary material: sn.pub/extras

Verwandte Artikel